Buy Chiasma Stock | CHMA Stock Price & Latest News | Public
CHMA

Chiasma

$0.00 (0.00%)Today
    Small Market Cap

    About CHMA

    Chiasma, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing and commercializing oral forms of therapies that are available by injection. Its products include octreotide capsules and clinical trials. The firm's Transient Permeability...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.17
    -0.33
    -0.5
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.35

    Actual EPS
    Q4 2020

    Stats

    Market Cap$230,63M
    Volume48,64k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.75
    1 Year Low$2.88
    Open$4.25
    High$4.51
    Low$4.24

    Buy any stock with any amount of money.

    Download the App
    Download the app